Records containing: Non-Alcoholic Fatty Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-05Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-03-05Prognostic Significance of Fatty Liver Disease in Bariatric Patients
-
CLINICAL_TRIALS study record update · 2025-02-13Change of Adipose Tissues and Triglyceride in Obese Patients With Non-alcoholic Fatty Liver Disease After Bariatric Surgery or Life-style Intervention
-
CLINICAL_TRIALS study record update · 2025-02-03Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals - Extended Validation.
-
CLINICAL_TRIALS study record update · 2025-01-31Pyramidal Versus Continuous Training Effects on Fatty Liver
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-16Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
-
CLINICAL_TRIALS study record update · 2024-12-09Nonalcoholic Fatty Liver Disease: Crosstalk Between Genetic Predisposition and Epigenetic Lysosomal Acid Lipase Activity Reduction in Blood, Plasma and Platelets
-
CLINICAL_TRIALS study record update · 2024-12-05The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults
-
CLINICAL_TRIALS study record update · 2024-11-26A Parallel, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial of the Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Both Men and Women with MASLD
-
CLINICAL_TRIALS study record update · 2024-11-22A Randomised Double-blind Controlled Trial on Tocotrienol as a Treatment for Non-alcoholic Fatty Liver
-
CLINICAL_TRIALS study record update · 2024-11-21Diet Intervention to Promote Liver and Brain Health in Adults With Non-alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2024-11-19Cardiovascular Diseases (CVD) and Nonalcoholic Fatty Liver Diseases (NAFLD) Among Gallstone and Cholecystectomy Patients and the Impact of a Novel Diet and Muscle Training Program
-
CLINICAL_TRIALS study record update · 2024-11-12The Efficacy of Soluble Fibre Supplementation for the Treatment of Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2024-10-31Intermittent Fasting Versus Dietary Approach to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients
-
CLINICAL_TRIALS study record update · 2024-10-30Effects of a Time-restricted Hypocaloric Mediterranean Diet in Patients with Non-alcoholic Fatty Liver Disease on Glucose Metabolism (CHRONO-NAFLD Project)
-
CLINICAL_TRIALS study record update · 2024-10-24A Phase 2, Prospective, Multicenter, Double-blind, Randomized Study of Saroglitazar Magnesium 1 mg, 2 mg or 4 mg Versus Placebo in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2024-10-22A Care Path for the Detection of Advanced NAFLD-fibrosis: the Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study - the NLA2 Study
-
CLINICAL_TRIALS study record update · 2024-10-18Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study
-
CLINICAL_TRIALS study record update · 2024-10-15Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
-
CLINICAL_TRIALS study record update · 2024-10-09Retrospective and Prospective Study Aimed At the Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on the Prognosis of Non-alcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2024-09-26Treating Pediatric NAFLD with Nutrition
-
CLINICAL_TRIALS study record update · 2024-09-20A PHASE 1, 3-PART, SPONSOR OPEN STUDY OF PF-07202954 IN HEALTHY ADULTS: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE (IN PART 1), AND REPEATED (IN PART 2), ESCALATING, ORAL DOSES ALONG WITH CONDITIONAL PART 3 OF RANDOMIZED, OPEN-LABEL ASSESSMENT OF EFFECT OF FOOD ON PF-07202954 EXPOSURE
-
CLINICAL_TRIALS study record update · 2024-09-19Technical Validation of Magnetic Resonance Biomarkers of Obesity-Associated Non-Alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2024-09-19Prospective Single-centre, Open-label Study to Assess the Pharmacokinetics of Cholyl-lysl-fluorescein (NRL972) in Patients with Clinical Evidence for NAFLD: Supporting the Disease Staging Into Fatty Liver Disease Versus NASH
-
CLINICAL_TRIALS study record update · 2024-09-05Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis